SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921530-02-000145
Filing Date
2002-02-14
Accepted
2002-02-14 00:00:00
Documents
3
Group Members
GEORGE SOROSQIH MANAGEMENT INVESTOR, L.P.QIH MANAGEMENT, INC.QUANTUM INDUSTRIAL PARTNERS LDC

Document Format Files

Seq Description Document Type Size
1 praecis_13ga1-123101.txt SC 13G/A 18288
3 EXHIBIT A - POWER OF ATTORNEY praecis_13gexha-123101.txt EX-24 2536
4 EXHIBIT B-POWER OF ATTORNEY praecis_13gexhb-123101.txt EX-24 2984
  Complete submission text file 0000921530-02-000145.txt   26186
Mailing Address C/O AKIN, GUMP, STRAUSS,HAUER,FELD, 399 PARK AVENUE NEW YORK NY 10022
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 2128721054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

IRS No.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address ONE HAMPSHIRE ST CAMBRIDGE MA 02139-1572
Business Address ONE HAMPSHIRE ST CAMBRIDGE MA 02139-1572 6174948400
PRAECIS PHARMACEUTICALS INC (Subject) CIK: 0001033025 (see all company filings)

IRS No.: 043200305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60009 | Film No.: 02546778
SIC: 2834 Pharmaceutical Preparations